Page 45 - Accept Exception Requests News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accept exception requests. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accept Exception Requests Today - Breaking & Trending Today

Welcome To IANS Live - NATION - Gujarat Cong chief, Oppn leader resign accepting poll debacle


Photo Credit: IANS
IANSLive
Gandhinagar, March 3 (IANS) The Gujarat Congress chief Amit Chavda and the Leader of Opposition Party (LoP) Paresh Dhanani tendered resignations from their posts on Tuesday, following the party s debacle in the local body elections in Gujarat. The Congress leadership accepted their resignations. However, both will continue till the party finds their replacement.
To get full access of the story, click here to subscribe to IANS News Service
© 2021 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.
For news, views and gossips, follow IANS at Twitter. ....

Amit Chavda , News Service , India Private , Gujarat Congress , Leader Of Opposition Party Lop Paresh Dhanani , Gujarat Cong , Opposition Party , Paresh Dhanani , All Rights , அமித் சவ்தா , செய்தி சேவை , இந்தியா ப்ரைவேட் , குஜராத் காங்கிரஸ் , தலைவர் ஆஃப் எதிர்ப்பு கட்சி லாப் பரேஷ் தாணநி , குஜராத் காங் , எதிர்ப்பு கட்சி , பரேஷ் தாணநி , அனைத்தும் உரிமைகள் ,

EMA Accepts Pfizer's MAA For 20-valent Pneumococcal Conjugate Vaccine Candidate For Adults


EMA Accepts Pfizer s MAA For 20-valent Pneumococcal Conjugate Vaccine Candidate For Adults
NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) said the European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) for its 20-valent pneumococcal conjugate vaccine candidate for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes in adults 18 years of age and older.
The epidemiology of pneumococcal serotypes causing disease has been changing due to the success of pneumococcal conjugate vaccines targeting pediatric and adult populations. In many countries across Europe and around the world, more than half of all cases of invasive pneumococcal disease in older adults are due to the 20 serotypes covered in 20vPnC, including seven serotypes (8, 10A, 11A, 12F, 15B, 22F, and 33F) that are not included in any currently licensed pneumococcal conjugate vaccine, said Kathrin U. Jansen, Senior Vice President and Head of V ....

Kathrinu Jansen , Pfizer Inc , Head Of Vaccine Research , European Medicines Agency , Marketing Authorization Application , Senior Vice President , Vaccine Research , ஃபைசர் இன்க் , தலை ஆஃப் தடுப்பூசி ஆராய்ச்சி , சந்தைப்படுத்தல் அங்கீகாரம் விண்ணப்பம் , மூத்தவர் துணை ப்ரெஸிடெஂட் , தடுப்பூசி ஆராய்ச்சி ,

Pfizer Inc.: EMA Accepts Marketing Application for Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency


(2)
- If approved, somatrogon will serve as a once-weekly treatment option -
Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the European Medicines Agency (EMA) has validated for review the Marketing Authorization Application (MAA) for somatrogon, a long-acting recombinant human growth hormone that is intended to be administered once-weekly for the treatment of pediatric patients with growth hormone deficiency (GHD). Pfizer expects a decision from the European Commission in 2022.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210226005102/en/
Today s announcement is an example of our decades-long commitment to actively support the pediatric growth hormone deficiency community through therapeutic options that help children reach their full potential, said Brenda Cooperstone, MD, Chief Development Officer, Rare Disease, Pfizer Global Product Development. If approved in t ....

United States , Andrew Widger , Chuck Triano , Phillip Frost , Brenda Cooperstone , European Commission , Pfizer Global Product Development , Health Inc , Exchange Commission , Pfizer Inc , European Medicines Agency , Marketing Authorization Application , Chief Development Officer , Rare Disease , Pfizer Global Product , Orphan Drug , Annual Reports , Looking Information , Factors That May Affect Future , Statement Regarding Forward Looking , ஒன்றுபட்டது மாநிலங்களில் , பிலிப் பனி , ஐரோப்பிய தரகு , ஃபைசர் உலகளாவிய ப்ராடக்ட் வளர்ச்சி , ஆரோக்கியம் இன்க் , பரிமாற்றம் தரகு ,

Tourism players welcome Capitol's move to accept visitors from other provinces


SunStar
Cebu Provincial Capitol building (SunStar File)
+
February 23, 2021
STAKEHOLDERS in the tourism industry welcome the move of the Cebu Provincial Government to ease travel for local tourists from other provinces who want to experience and enjoy Cebu’s destinations.
Following the meeting of the Provincial Tourism Task Force on Friday, Feb. 19, tour operators are now planning to form travel packages and ask airlines to offer cost-efficient packages for visitors wanting to visit any of Cebu’s 44 towns and six component cities.
Andrew Teh, member of the Cebu Travel & Tours Association and Cebu Alliance of Tour Operations Specialists, said they are initially thinking of coming up with cheap package tours that include a two- or three-night stay and a tour of some destinations. ....

Gwendolyn Garcia , Mactan Cebu International Airport , Cebu Provincial Task , Cebu Alliance Of Tour Operations Specialists , Tourism Task Force On , Cebu Travel Tours Association , Tourism Task , Megawide Corporation , Cebu Provincial Government , Provincial Tourism Task Force , Cebu Travel , Tours Association , Cebu Alliance , Tour Operations Specialists , Cebu Governor Gwendolyn Garcia , Executive Order , Mactan Cebu International , Cebu Province , குவெண்தொளிய்ன் கார்சியா , ஸிபூ மாகாண பணி , ஸிபூ கூட்டணி ஆஃப் சுற்றுப்பயணம் செயல்பாடுகள் வல்லுநர்கள் , சுற்றுலா பணி படை ஆன் , ஸிபூ பயணம் சுற்றுப்பயணங்கள் சங்கம் , சுற்றுலா பணி , ஸிபூ மாகாண அரசு , மாகாண சுற்றுலா பணி படை ,